Hypercalcaemia and Maternal exposure during pregnancy

Summary:

Maternal exposure during pregnancy is found among people with Hypercalcaemia, especially for people who are female, 30-39 old.

The study analyzes which people have Maternal exposure during pregnancy with Hypercalcaemia. It is created by eHealthMe based on reports of 85 people who have Hypercalcaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypercalcaemia?

Hypercalcaemia (elevated calcium (ca+) level in the blood) is found to be associated with 1,065 drugs and 1,016 conditions by eHealthMe. Check the latest studies of Hypercalcaemia.

What is Maternal exposure during pregnancy?

Maternal exposure during pregnancy (use of substance during pregnancy) is found to be associated with 1,328 drugs and 1,527 conditions by eHealthMe. Check the latest studies of Maternal exposure during pregnancy.



On Jul, 07, 2026

85 people who have Hypercalcaemia and Maternal Exposure During Pregnancy are studied.

Would you have Maternal exposure during pregnancy when you have Hypercalcaemia?

Gender of people who have Hypercalcaemia and experienced Maternal Exposure During Pregnancy *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Hypercalcaemia and experienced Maternal Exposure During Pregnancy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 8.33 %
  • 20-29: 26.39 %
  • 30-39: 50.0 %
  • 40-49: 15.28 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Hyperparathyroidism Primary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium- primary): 10 people, 11.76%
  2. Nausea (feeling of having an urge to vomit): 8 people, 9.41%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 8.24%
  4. Morning Sickness (sickness in morning during pregnancy): 7 people, 8.24%
  5. Nausea And Vomiting: 5 people, 5.88%
  6. High Blood Pressure: 5 people, 5.88%
  7. Maternal Therapy To Enhance Foetal Lung Maturity: 4 people, 4.71%
  8. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 3 people, 3.53%
  9. Blood Calcium Increased: 3 people, 3.53%
  10. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 2.35%

Common drugs taken by these people *:

  1. Cinacalcet Hydrochloride: 14 people, 16.47%
  2. Sodium Chloride: 10 people, 11.76%
  3. Folic Acid: 9 people, 10.59%
  4. Calcium Carbonate: 8 people, 9.41%
  5. Pantoprazole: 7 people, 8.24%
  6. Zoledronic Acid: 7 people, 8.24%
  7. Metoclopramide: 7 people, 8.24%
  8. Calcitonin Salmon: 6 people, 7.06%
  9. Furosemide: 5 people, 5.88%
  10. Calcium: 5 people, 5.88%

Common symptoms for these people *:

  1. Drug Ineffective: 38 people, 44.71%
  2. Premature Delivery: 20 people, 23.53%
  3. Normal Newborn: 17 people, 20.00%
  4. Nausea (feeling of having an urge to vomit): 13 people, 15.29%
  5. Blood Calcium Increased: 9 people, 10.59%
  6. Diabetes Insipidus (diabetes caused by a deficiency of the pituitary hormone vasopressin, which regulates kidney function): 7 people, 8.24%
  7. High Blood Pressure: 7 people, 8.24%
  8. Blood Creatinine Increased: 6 people, 7.06%
  9. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 6 people, 7.06%
  10. Nausea And Vomiting: 6 people, 7.06%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Maternal exposure during pregnancy?

- Check whether Maternal exposure during pregnancy is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Maternal exposure during pregnancy:

All the conditions that are associated with Maternal exposure during pregnancy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Maternal exposure during pregnancy and Hypercalcaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: